The sleep-wake cycle and Alzheimer's disease: what do we know?

146Citations
Citations of this article
301Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Sleep-wake disturbances are a highly prevalent and often disabling feature of Alzheimer's disease (AD). A cardinal feature of AD includes the formation of amyloid plaques, associated with the extracellular accumulation of the amyloid-β (Aβ) peptide. Evidence from animal and human studies suggests that Aβ pathology may disrupt the sleep-wake cycle, in that as Aβ accumulates, more sleep-wake fragmentation develops. Furthermore, recent research in animal and human studies suggests that the sleep-wake cycle itself may influence Alzheimer's disease onset and progression. Chronic sleep deprivation increases amyloid plaque deposition, and sleep extension results in fewer plaques in experimental models. In this review geared towards the practicing clinician, we discuss possible mechanisms underlying the reciprocal relationship between the sleep-wake cycle and AD pathology and behavior, and present current approaches to therapy for sleep disorders in AD.

Cite

CITATION STYLE

APA

Lim, M. M., Gerstner, J. R., & Holtzman, D. M. (2014). The sleep-wake cycle and Alzheimer’s disease: what do we know? Neurodegenerative Disease Management. https://doi.org/10.2217/nmt.14.33

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free